This year will be big for legislation and regulatory reform, CHPNZ Executive Director Scott Milne says.
“We have the Natural Products Bill now being absorbed into an enlarged Therapeutic Products Bill. And this legislation has already signalled substantial changes to the medical devices part of our industry.
New Zealand’s Sunscreen (Product Safety Standard) Bill was enacted on March 8, 2022. What should interest CHPNZ members are the signals in the third reading of the Bill on March 2
Pharma sales reps must become virtually savvy and harness the power of artificial intelligence as COVID- 19 forces a major reinvention of the role, the Reuters Pharma 2020 conference has been told.
Are we yet ready to go back into the office? This is the big question facing pharma as it approaches the end of what has been a year marked by unprecedented disruption, pivoting, agility, collaboration and the increased use of athletic wear as work clothes.
